99% Pure / Made in USA / Multidose
The CJC-1295 (No DAC) / Ipamorelin blend is a dual-peptide formulation engineered for advanced research applications focused on optimizing natural growth hormone (GH) signaling through a synergistic and physiologically aligned approach.
By combining a short-acting GHRH analog with a selective growth hormone secretagogue, this blend provides a comprehensive model for studying GH release, IGF-1 signaling, recovery pathways, and metabolic regulation in a controlled research environment.
This formulation works through two complementary pathways to enhance GH signaling:
Together, this dual-pathway activation allows researchers to study clean, controlled GH stimulation while maintaining physiological balance and timing.
Synergistic GH Optimization
Unlike single-compound models, this blend enables a more complete representation of GH signaling. Research has explored its ability to:
Because both compounds are short-acting, this blend is particularly valuable in research requiring precision control over hormone timing. Studies have examined its role in:
The combined mechanism of this blend makes it highly relevant in recovery-focused research models. It has been studied for its ability to:
This blend is also widely studied in metabolic and endocrine research, with potential relevance in:
A key advantage of this formulation is its targeted and selective activity:
For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Scroll for More >>
Made in USA
A combined peptide formulation prepared without DAC, manufactured for research environments requiring precise compound handling and consistent batch characteristics.
$80.00
IMPORTANT: Research Use Only
By entering this website, you acknowledge that all products sold by Newbridge Peptides are intended strictly for research purposes only. They are not for human or animal consumption, medical use, or any use not permitted by applicable law.